Cubist Systematic Strategies, LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 64 filers reported holding CTI BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2022$828,142
-46.1%
137,794
-47.8%
0.01%
-44.4%
Q3 2022$1,536,000
+303.1%
263,956
+313.6%
0.01%
+350.0%
Q2 2022$381,000
-84.7%
63,823
-88.0%
0.00%
-90.5%
Q1 2022$2,483,000
+4498.1%
531,600
+2820.4%
0.02%
+2000.0%
Q3 2021$54,000
-57.8%
18,203
-64.5%
0.00%0.0%
Q2 2021$128,000
+75.3%
51,287
+105.0%
0.00%0.0%
Q1 2021$73,00025,0210.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,000,000$3,881,0002.23%
BVF INC/IL 6,929,690$6,723,0000.75%
CAXTON CORP 323,026$313,0000.29%
NEA Management Company, LLC 3,750,000$3,638,0000.19%
Orbimed Advisors 5,000,000$4,851,0000.08%
Fosun International Ltd 300,428$288,0000.02%
OXFORD ASSET MANAGEMENT LLP 105,385$102,0000.00%
A.R.T. Advisors, LLC 30,055$29,0000.00%
Renaissance Technologies 1,282,352$1,244,0000.00%
WASHINGTON TRUST Co 16,000$15,0000.00%
View complete list of CTI BIOPHARMA CORP shareholders